Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCK | P35557 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16686072 | 1.00 | GCK (0.43) | GCKLMNASNCAPKMCYP1A2 | |
| SCHEMBL18153585 | 0.79 | KMT2A (0.53) | LMNAKMT2AMAPTKDM4EMEN1 | |
| SCHEMBL16685494 | 0.79 | KMT2A (0.53) | LMNAKMT2AMAPTKDM4EMEN1 | |
| SCHEMBL20112821 | 0.78 | MAPT (0.54) | CYP1A2GAACYP2C9CYP2C19KMT2A | |
| SCHEMBL15525568 | 0.78 | KMT2A (0.58) | LMNAPKMCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL15525567 | 0.78 | KMT2A (0.58) | LMNAPKMCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL18983184 | 0.77 | XDH (0.48) | LMNAPKMGAAKMT2AMAPT | |
| SCHEMBL16685883 | 0.77 | XDH (0.48) | LMNAPKMGAAKMT2AMAPT | |
| SCHEMBL16696289 | 0.76 | PTGS2 (0.54) | SNCAPKMCYP1A2CYP2C19KMT2A | |
| SCHEMBL18165781 | 0.75 | NPC1 (0.44) | LMNASNCAPKMGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3267995-B1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | UNIV CASE WESTERN RESERVE (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250295640-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | CASE WESTERN RESERVE UNIVERSITY | 2025-09-25 | — | — | US | disclosed |
| US-20240100026-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2024-03-28 | — | — | US | disclosed |
| US-20230285402-A1 | Compositions and Methods of Modulating Short-Chain Dehydrogenase Activity | UNIV TEXAS (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230136730-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20210283113-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | CASE WESTERN RESERVE UNIVERSITY | 2021-09-16 | — | — | US | disclosed |
| US-20210106587-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | UNIV CASE WESTERN RESERVE (US) | 2021-04-15 | — | — | US | disclosed |
| US-20210100778-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | THE UNIVERSITY OF IOWA | 2021-04-08 | — | — | US | disclosed |
| US-10945998-B2 | Inhibitors of short-chain dehydrogenase activity for treating fibrosis | CASE WESTERN RESERVE UNIVERSITY (US) | 2021-03-16 | — | — | US | disclosed |
| US-10869871-B2 | Compositions and methods of modulating short-chain dehydrogenase activity | CASE WESTERN RESERVE UNIVERSITY (US) | 2020-12-22 | — | — | US | disclosed |
| US-20190275014-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING CELL DEATH | CASE WESTERN RESERVE UNIVERSITY (US) | 2019-09-12 | — | — | US | disclosed |
| EP-3057973-B1 | COMPOSITIONS COMPRISING A 15-PGDH INHIBITOR FOR THE HEALING OF WOUNDS | UNIV CASE WESTERN RESERVE (US) | 2019-09-04 | — | — | EP | disclosed |
| EP-3484473-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | Case Western Reserve University (US) | 2019-05-22 | — | — | EP | disclosed |
| US-20180064694-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | CASE WESTERN RESERVE UNIVERSITY | 2018-03-08 | — | — | US | disclosed |
| WO-2018017582-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | CASE WESTERN RESERVE UNIVERSITY (US) | 2018-01-25 | — | — | WO | disclosed |
| US-9789116-B2 | Compositions and methods of modulating short-chain dehydrogenase activity | CASE WESTERN RESERVE UNIVERSITY (US) | 2017-10-17 | — | — | US | disclosed |
| US-20170173028-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136730-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | GCK 1130/4885LMNA 1481/4885SNCA 3966/4885 |
| US-20240100026-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | HPGD, GCDH, DCX | GCK 2234/4885LMNA 1628/4885SNCA 1823/4885 |
| US-20210100778-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | HPGD, GCDH, DCX | GCK 2234/4885LMNA 1628/4885SNCA 1823/4885 |
| US-20210106587-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | GCK 1130/4885LMNA 1481/4885SNCA 3966/4885 |
| US-20230285402-A1 | Compositions and Methods of Modulating Short-Chain Dehydrogenase Activity | HPGD, GCDH, HPGDS | GCK 1130/4885LMNA 1481/4885SNCA 3966/4885 |
| US-10869871-B2 | Compositions and methods of modulating short-chain dehydrogenase activity | HPGD, GCDH, HPGDS | GCK 1130/4885LMNA 1481/4885SNCA 3966/4885 |
| US-20190275014-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING CELL DEATH | HPGD, DCX, GCDH | GCK 2177/4885LMNA 1909/4885SNCA 2281/4885 |
| US-20180064694-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | GCDH, HPGD, UGDH | GCK 1946/4885LMNA 1656/4885SNCA 4265/4885 |
| US-20250295640-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | GCDH, HPGD, UGDH | GCK 1946/4885LMNA 1656/4885SNCA 4265/4885 |
| US-20210283113-A1 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS | GCDH, HPGD, UGDH | GCK 1946/4885LMNA 1656/4885SNCA 4265/4885 |
| US-10945998-B2 | Inhibitors of short-chain dehydrogenase activity for treating fibrosis | GCDH, HPGD, UGDH | GCK 1946/4885LMNA 1656/4885SNCA 4265/4885 |
| US-20170173028-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | GCK 1130/4885LMNA 1481/4885SNCA 3966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.